Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bone Marrow Transplantation|November 15, 2011
Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenanceT Ahmadi, J McQuade, D Porter, et al.
Bone Marrow Transplantation|October 25, 2011
Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomasV R Paralkar, S D Nasta, K Morrissey, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2006
Treatment of PTLD with rituximab or chemotherapyR L Elstrom, C Andreadis, N A Aqui, et al.
Bone Marrow Transplantation|March 15, 2005
Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantationA W Loren, S M Luger, E A Stadtmauer, et al.
Bone Marrow Transplantation|October 6, 2005
Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphomaC Andreadis, S J Schuster, E A Chong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomasG Ghilardi, E A Chong, J Svoboda, et al.
Pageof 1